Submitted by Anonymous (not verified) on 30 April 2025 - 13:00
Human medicines European public assessment report (EPAR): Filspari, Sparsentan, Date of authorisation: 19/04/2024, Revision: 2, Status: Authorised
Source:
Human medicines European public assessment report (EPAR): Filspari, Sparsentan, Date of authorisation: 19/04/2024, Revision: 2, Status: Authorised